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Abstract. obesity correlates with an increased risk of devel‑
oping prostate cancer (Pca) and leptin plays an important role 
in Pca progression. Since leptin is produced by adipocytes, 
the serum leptin level is higher in obese than in non‑obese 
individuals. However, the effects of leptin remain controversial 
and unclear. the aim of the present study was to investigate the 
effect of leptin on Pca cell aggressiveness. three human Pca 
cell lines (lncaP, Du145 and Pc‑3) were treated with recom‑
binant leptin for 28 days. cell proliferation, migration, and 
invasion were estimated using the WSt assay, a wound‑healing 
assay, and a BD Matrigel invasion assay, respectively. the 
mechanism underlying the proliferative effect of leptin was 
investigated by cell transfections with small interfering 
rna (sirna) against the leptin receptor (obr) or forkhead 
box o1 (foXo1), and by immunocytochemistry. long‑term 
exposure of Pca cells to leptin enhanced their proliferation, 
migration and invasion. leptin increased obr expression 
and enhanced akt phosphorylation constitutively. leptin also 
increased the phosphorylation of foXo1 via Pi3K signaling 
and foXo1 gene silencing enhanced Pca cell proliferation. 
leptin induced the translocation of foXo1 from the nucleus 
to the cytoplasm. furthermore, the Pi3K inhibitor, ly294002 
suppressed this translocation. these results suggested that 
leptin regulated the subcellular localization of foXo1 and 
induced akt phosphorylation. additionally, we revealed that 
leptin increased the expression of cyclin D1 and decreased the 
expression of p21 protein. in conclusion, long‑term exposure to 
leptin increased the cell proliferation, migration, and invasion 
of Pca cells through inactivation of foXo1. this inactivation 
resulted from exclusion of foXo1 from the nucleus and its 
restriction to the cytoplasm through Pi3K/akt signaling. our 
findings contribute to an understanding of the association 
between obesity and Pca aggressiveness.
Introduction
in japan, dietary changes favoring more Western eating 
habits have resulted in an increased rate of obesity (1). the 
prevalence of obesity in adult men has increased since the 
1970s, according to the data of the japanese Ministry of 
Health, labour and Welfare (tokyo, japan) (2). obesity has 
become a major social and health issue. obesity is related to 
an increased risk of not only metabolic diseases including 
cardiovascular disease, hypertension, and diabetes, but also of 
various cancers, particularly those with a hormonal basis such 
as breast and prostate cancer (Pca) (3). indeed, the incidence of 
Pca has been increasing annually since the early 1990s in the 
japanese population. Pca is predicted to become the second 
most common cancer among all cancers of japanese men by 
2020 (4). However, the relationship between Pca and obesity 
remains controversial, with some studies indicating that 
obesity is associated with a decreased incidence of Pca, and 
other studies suggesting an increased incidence and a worse 
survival among obese men (5‑7). Several reports, including the 
comment by freedland (8), have suggested that obesity might 
be more important as a risk factor for Pca progression rather 
than for its incidence.
leptin, a 16‑kDa polypeptide adipokine that is secreted 
predominantly by adipose tissue, is considered to be involved 
in satiety regulation in humans and animals (9). in adults, 
circulating leptin levels are closely related to the amount 
of adipose tissue (10), so that serum leptin level is elevated 
in obese individuals compared to non‑obese individuals. 
leptin acts as a regulatory signal for the central nervous 
system, reflects adipose tissue stores, and influences energy 
homeostasis, eating behavior, appetite regulation and energy 
expenditure (11). leptin also plays a role in reproduction, 
hematogenesis, neovascularization and cancer cell prolifera‑
tion (12,13).
Several studies have investigated the relationship between 
obesity, plasma leptin levels, and Pca. chang et al (14) showed 
that men with elevated leptin levels had an increased risk of 
diagnosis with high‑volume disease. it has also been shown 
that high leptin levels correlate with high stage and high grade 
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of Pca (15). High expression levels of leptin and leptin receptor 
(obr), which is a member of the class i cytokine‑receptor 
family, have been reported in prostate tissues (16); therefore, 
leptin may play an important role in the process of carcinogen‑
esis and progression of prostate tumors.
Several recent in vitro studies have indicated that leptin 
acts as a mitogenic factor for various cell types including both 
normal and neoplastic cells (17,18). obrs have been identi‑
fied in prostate cell membranes (19), and appear to function 
in activation of mitogenic signaling pathways (20,21). in those 
studies, the proliferative effects of leptin on the androgen‑sensi‑
tive (aS) Pca cell line, lncaP, were less pronounced than its 
effects on the androgen‑resistant lines, Du145 and Pc‑3. in 
contrast to these reported proliferative effects of leptin on only 
androgen‑insensitive (ai) cell lines, Deo et al have suggested 
that leptin induces the proliferation of only aS cell lines (22). 
they reported a dose‑dependent increase in proliferation when 
lncaP cells were cultured with leptin, but no changes in the 
growth of ai cells, even if they were incubated with a high 
dose of leptin. thus, the effects of leptin on the growth of Pca 
cells remain controversial. in addition, the exact mechanism 
by which leptin exerts proliferative effects on cancer cells, 
including Pca cells, is not fully understood.
in the present study, we investigated the effects of leptin on 
the growth of both aS and ai Pca cells and on the underlying 
mechanisms of leptin action. Because exposure to elevated 
leptin levels for a long time is expected to result in higher 
Pca risk or higher Pca tumor aggressiveness in humans, 
the present study was performed using Pca cells that were 
cultured in medium containing various concentrations of 
leptin for 28 days.
Materials and methods
Materials. rPMi‑1640 and Ham's f12 media for cell culture 
were supplied by Wako Pure chemical industries, ltd. (osaka, 
japan) and life technologies (carlsbad, ca, uSa), respec‑
tively. fetal bovine serum (fBS) was obtained from nichirei 
Biosciences, inc. (tokyo, japan). Monoclonal antibody against 
human β‑actin and polyclonal rabbit antibodies against human 
obr, and phosphorylated forkhead box o1 (foXo1) (Ser256) 
were purchased from Sigma‑aldrich japan K.K. (tokyo, 
japan) and abcam (tokyo, japan), respectively. ly294002, 
used as an Pi3K inhibitor, and polyclonal rabbit antibodies 
against phosphorylated akt, akt, cyclin D1, p21cip1 and 
lamin a/c were obtained from cell Signaling technology, 
inc. (Danvers, Ma, uSa). Polyclonal rabbit antibody against 
foXo1 was obtained from Santa cruz Biotechnology, inc. 
(Santa cruz, ca uSa).
Cell culture and treatment. the aS human Pca cell line 
lncaP and the ai human Pca cell lines Du145 and Pc‑3 
used in this study were purchased from the american type 
culture collection (atcc) (rockville, MD, uSa). lncaP 
and Du145 cells were maintained in rPMi‑1640 medium and 
Pc‑3 cells were maintained in Ham's f‑12 medium. Media 
were supplemented with 10% heat‑inactivated fBS in the pres‑
ence or absence of human recombinant leptin (Sigma aldrich) 
at the indicated concentrations, in a humidified incubator at 
37˚C and 5% CO2. the medium was changed every 4 days. 
Cells were passaged when they were 50‑70% confluent. Cells 
were transferred into serum‑free medium and cultured for 24 h 
under the same conditions except for the absence of serum.
Western blots. cells were lysed with ice‑cold lysis buffer 
and protease inhibitor and phosphatase inhibitor cocktails 
(Sigma‑aldrich). Samples were centrifuged at 12,000 x g 
for 10 min at 4˚C, and supernatants were electrophoresed on 
sodium dodecyl sulfate (SDS)‑polyacrylamide gels and trans‑
ferred to polyvinylidene difluoride membranes (Millipore, 
Bedford, Ma, uSa). after blocking with 5% skimmed milk, 
the membranes were probed with primary antibodies over‑
night at 4˚C, followed by horseradish peroxidase‑conjugated 
secondary antibody (ge Healthcare, Buckinghamshire, uK) 
for 1 h at room temperature. the immune complexes were 
visualized with the enhanced chemiluminescence Plus detec‑
tion system (ge Healthcare) according to the manufacturer's 
instructions.
Gene silencing with siRNA. for small interfering rna 
(sirna) experiments, sirna cocktails were obtained 
from, and functionally annotated by cosmo Bio co., ltd. 
(tokyo, japan) and Bioneer, inc. (alameda, ca, uSa). the 
sirna cocktails are indicated in table i. for the control, 
non‑targeting sirna (cat. no. 4390844) was obtained from 
Thermo Fisher Scientific, Inc. (Waltham, MA, USA). Cells 
were transiently transfected with each sirna or control 
sirna cocktail using the neon transfection System (life 
technologies). after 48‑h incubation, cells were utilized for 
each assay.
Cell proliferation assay. the relative effect of leptin on the 
proliferation of each cell line was assessed using WSt‑8 assays 
and a cell counting kit‑8 (Dojindo, Kumamoto, japan). cells 
that had been cultured in the presence or absence of graded 
concentrations of leptin for each day were re‑seeded in 96‑well 
plates at a density of 3x103 cells/well and were cultured in the 
same graded concentrations of leptin in at least three repli‑
cate wells at 37˚C for 48 h. The WST‑8 reagent was added 
to each well, and the cells were further incubated for another 
3 h. absorbance was determined using a spectrophotometer 
(Thermo Scientific Multiskan FC; Thermo Fisher Scientific, 
inc.) at 450 nm. absorbance values were expressed as percent‑
ages relative to untreated controls.
Cell invasion assay. the cell invasion assay was performed 
using a Matrigel invasion chamber from Becton‑Dickinson 
(BD Biosciences, tokyo, japan) according to the manufac‑
turer's instructions. approximately 3x104 cells that had been 
cultured in the presence or absence of 100 ng/ml of leptin 
for 28 days were seeded onto the top of chamber and were 
incubated at 37˚C in a 5% CO2 incubator. after 48‑h incuba‑
tion, the media were aspirated, and the cells remaining on 
the upper surface of the membrane and the Matrigel Matrix 
were removed with a sterile cotton swab. invasive cells on the 
bottom surface of the membrane that had passed through the 
Matrigel were fixed in methanol and stained with Diff‑Quik 
stain (Sysmex Corp., Hyōgo, Japan). The number of invaded 
cells on four representative sections of each membrane was 
counted in high‑power fields under a light microscope (BX63; 
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olympus corp., tokyo, japan). Percent invasion, which was 
the percent of the seeded cells that had passed through the 
Matrigel, was calculated. the assay was repeated at least 
three times.
Scratch wound‑healing migration assay. cells that had been 
cultured in the presence or absence of 100 ng/ml of leptin 
for 28 days were seeded into 6‑well plates and cultured in at 
least three replicate wells at 37˚C. When cells were grown to 
figure 1. effects of long‑term leptin exposure on the proliferation, invasion, and migration of human prostate cancer (Pca) cells. (a) lncaP cells were 
cultured in serum‑free media for 48 h in the presence or absence of leptin (0‑1,000 ng/ml) and cell numbers were determined using a colorimetric WSt 
assay. (B) time‑course effects of proliferation of lncaP cells cultured in the medium with 100 ng/ml leptin. (c) effects of leptin at various concentrations 
for 28 days on the cell proliferation. (D) cell invasion assay. the number of cells that invaded through the Matrigel was counted in four different regions. 
Photographs of representative images were taken at x200 magnification. Scale bar, 100 µm. The data indicate percent invasion, i.e., the rates of the number of 
cells through Matrigel insert to control insert. (e) Scratch wound‑healing assays. the reduction in the wound area was calculated using imagej. Values are 
expressed as means ± standard deviation (SD). *P<0.05.
Table Ⅰ. The siRNA used in this study.
sirna Sense (5'→3') antisense (5'→3')
obr ggaagauguaugagguuuatt uaaaccucauacaucuucctt
 ggcuagauggacugggauatt uaucccaguccaucuagcctt
 ccagagugaugcagguuuatt uaaaccugcaucacucuggtt
foXo1 gcugcuguagauaaggacu aguccuuaucuacagcagc
 guccaagacauagcugguu aaccagcuaugucuuggac
 cugcauagcaucaagucuu aagacuugcugcuaugcag
sirna, small interfering rna; obr, leptin receptor; foXo1, forkhead box o1.
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90% or above confluence, a crossing linear scratch was made 
with a 200‑µl pipette tip, and floating cells were removed by 
washing with phosphate‑buffered saline (PBS). these plates 
were photographed at the identical location both before and 
18 h after incubation. the average area of the open scratch 
area was calculated using imagej ver 1.46r (niH, Bethesda, 
MD, uSa).
Immunofluorescence. approximately 1x104 cells were seeded 
in a Lab‑Tek Ⅱ Chamber Slide (Thermo Fisher Scientific, Inc.). 
cells were then further cultured in serum‑free media for 48 h 
with the same leptin concentration. for Pi3K inhibition, cells 
were pre‑treated with ly294002 for 2 h. the cells were then 
fixed with 4% paraformaldehyde and permeabilized with PBS 
containing 0.2% triton X‑100 followed by blocking with 1% 
bovine serum albumin. thereafter, the cells were incubated 
with polyclonal anti‑foXo1 antibody followed by incubation 
with fluorescein isothiocyanate‑conjugated secondary anti‑
body (jackson immunoresearch labs, West grove, Pa, uSa). 
trihydrochloride (Hoechst 33342; Dojindo) staining was used 
for nuclear detection. fluorescence was photographed using 
an olympus iX71 microscope (olympus corp.).
Subcellular fractionation. Subcellular fractionation was 
carried out using nuclear/cytosol fractionation kits 
(BioVision, inc., Milpitas, ca, uSa) as described by the 
manufacturer. equal volumes of each fraction were loaded 
onto an SDS‑polyacrylamide gel, and western blotting was 
performed as previously described.
Statistical analysis. all values are expressed as the means ± stan‑
dard deviation (SD) of at least three independent experiments. 
Statistical analysis was performed using Student's unpaired 
t‑test. P<0.05 was considered statistically significant.
Results
Long‑term exposure to leptin enhances PCa cell proliferation, 
invasion and migration. to clarify the effect of leptin on Pca 
cell proliferation, lncaP, Du145 and Pc‑3 were treated with 
various concentrations of leptin for 48 h. fig. 1a‑c shows 
only results derived from lncaP cells, because the similar 
tendency was found in their experiments using three Pca 
cells examined. the incubation for 48 h did not affect the 
growth (fig. 1a). Because short‑term leptin exposure may not 
reflect the in vivo situation, we tried to examine the effects of 
long‑term leptin exposure. interestingly, time‑course experi‑
ments showed that cell growth reached maximum after 28‑day 
incubation with 100 ng/ml leptin (fig. 1B). the most effec‑
tive concentration of leptin was at 100 ng/ml (fig. 1c), thus, 
100 ng/ml was selected as the leptin concetration for further 
experiments. Maximum physiological concentration of serum 
leptin in human is ~100 ng/ml (10). these results indicated 
that treatment with 100 ng/ml leptin for 28 days might be the 
relevant condition for induction of proliferation of all Pca cells. 
We tested the effect of long‑term leptin treatment (1 month) on 
the ability of Pca cells to invade through Matrigel. as shown 
in fig. 1D, Pca cells that were treated long‑term with leptin 
showed significantly higher transit to the bottom surface of 
a Matrigel‑coated membrane than non‑leptin‑treated cells. 
in addition, the effect of long‑term leptin treatment on the 
migration ability of Pca cells was estimated using a scratch 
wound‑healing migration assay. as shown in fig. 1e, Pca 
cells treated long term with leptin showed a significantly larger 
healed area after scratching compared to non‑treated cells. 
thus, long‑term exposure to leptin enhanced the malignant 
potential of Pca cell lines.
Long‑term exposure to leptin increases ObR expression and 
Akt phosphorylation. next, the effect of long‑term leptin treat‑
ment on leptin‑induced intracellular signaling pathways in 
PCa cells was investigated. We first determined if the ObR and 
intracellular akt phosphorylation played a role in the enhanced 
proliferation observed in long‑term leptin‑treated cells. akt 
phosphorylation was assayed because several groups have 
previously demonstrated that leptin enhances cell proliferation 
via the Pi3K/akt signaling pathway. expression of the obr, 
as assessed by western blotting, was significantly increased 
by long‑term leptin treatment of all Pca cell lines, compared 
to non‑treated cells, as shown in fig. 2a. furthermore, we 
confirmed that the level of Akt phosphorylation increased in 
all Pca cell lines that were treated with leptin for 1 month 
compared to non‑treated cells.
ObR gene silencing and PI3K inhibitor suppress cell prolif‑
eration. to confirm that obr signaling played a role in 
leptin‑induced proliferation of PCa cells, ObR specific siRNA 
was transfected into Pca cells that had been exposed to leptin 
for 1 month. after 48‑h transfection, obr protein expression 
was markedly decreased in comparison to cells transfected 
with scrambled non‑specific siRNA (Fig. 2B). The silencing 
of ObR significantly decreased the proliferation of all PCa cell 
lines compared to control sirna cells. this result suggests 
that the obr receptor mediates leptin effects on proliferation.
to further analyze the role of akt activation in leptin‑ 
enhanced Pca cell proliferation, we used ly294002 to inhibit 
akt activation. following long‑term leptin culture, ly294002 
or control dimethyl sulfoxide (DMSo) was added for 2 h. and 
cells were incubated in serum‑free media for 48 h. as shown 
in fig. 2c, inhibition of akt phosphorylation with ly294002 
decreased cell proliferation in the absence of leptin and further 
suppressed leptin‑induced proliferation in lncaP cells. We 
observed similar results in Du145 and Pc‑3 (data not shown). 
these results suggest that the Pi3K/akt signaling pathway is 
important for leptin‑induced cell proliferation.
Long‑term exposure to leptin induces phosphorylation of 
FOXO1 via the PI3K/Akt signaling pathway. the Pi3K/akt 
signaling pathway has been reported to phosphorylate foXo1, 
which mediates some of its downstream signaling. to determine 
if foXo1 was involved in leptin‑mediated cellular effects, we 
first determined whether long‑term exposure to leptin induces 
phosphorylation of foXo1 using western blotting. as shown 
in fig. 3a, long‑term exposure to leptin induced a higher level 
of foXo1 phosphorylation than that of non‑treated cells. We 
further assayed if this phosphorylation is mediated by Pi3K/akt 
by assaying the effect of adding the specific PI3K inhibitor 
LY294002 (25 µM) for the last 2 h of long‑term leptin culture 
of Pca cells on foXo1 phosphorylation. following ly294002 
treatment foXo1 phosphorylation induced by leptin treatment 
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figure 3. role for forkhead box o1 (foXo1) in human prostate cancer (Pca) cell proliferation. (a) long‑term leptin exposure induces foXo1 phosphorylation 
that is inhibited by PI3K/Akt inhibition. For PI3K/Akt inhibition, 25 µM LY294002 was added for the last 2 h to cells with leptin. β‑actin was used as a loading 
control. (B) foXo1 downregulation enhances Pca cell proliferation. leptin‑untreated Pca cells were transfected with either foXo1 small interfering rnas 
(sirnas) (KD) or negative control sirnas (nc). numbers in the upper panel represent the average relative level of foXo1 expression which is normalized 
for β‑actin expression. Values are expressed as means ± standard deviation (SD). *P<0.05.
figure 2. Participation of leptin receptor (obr) and Pi3K/akt in human prostate cancer (Pca) cell proliferation. (a) Western blotting of the phosphorylation 
of akt at Ser473 and of obr expression. akt protein and β‑actin blots were used as loading controls. (B) assay of the proliferation of leptin‑treated Pca cells 
transfected with either obr small interfering rnas (sirnas) (KD) or negative control sirnas (nc) is shown. numbers in the upper panel represent the 
average relative level of obr expression, which is normalized for β‑actin expression. (c) assay of the proliferation of lncaP cells treated with either a Pi3K 
inhibitor or control dimethyl sulfoxide (DMSO) is shown. These cells were pre‑treated with LY294002 (25 µM) or DMSO for 2 h. Values are expressed as 
means ± standard deviation (SD). *P<0.05.
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was greatly reduced compared to control cells (fig. 3a). these 
results suggested that long‑term exposure to leptin induced 
phosphorylation of foXo1 via the Pi3K/akt signaling pathway.
FOXO1 gene silencing enhances PCa cell proliferation. to 
clarify the role of foXo1 in the proliferation of these Pca 
cell lines, we transiently transfected leptin‑untreated cells 
with foXo1 sirna. after 48‑h transfection, foXo1 protein 
expression was decreased in comparison to cells transfected 
with scrambled non‑specific siRNA (Fig. 3B). FOXO1 gene 
silencing significantly increased the proliferation of these cells 
compared to control cells (fig. 3B). these results indicated 
that foXo1 functions to suppress Pca cell proliferation.
Long‑term exposure to leptin regulates nuclear/cytoplasmic 
localization of FOXO1 via PI3K. one possible mechanism 
by which akt‑mediated phosphorylation of foXo1 might 
mediate foXo1 effects on leptin‑induced proliferation is by 
regulation of foXo1 cellular localization. thus, if foXo1 
is phosphorylated on specific residues by akt, foXo1 
can be excluded from the nucleus, thereby inactivating its 
transcriptional activity. To confirm the effect of long‑term 
exposure to leptin on the intracellular localization of foXo1, 
immunocytochemistry was performed. as shown in fig. 4a, 
foXo1 was expressed in both the nucleus and the cytoplasm 
in Du145 cells. in contrast, foXo1 expression in the nucleus 
was strongly decreased by long‑term leptin treatment. the 
addition of ly294002 to the medium with leptin restored 
the intra‑nuclear expression of foXo1 protein. We observed 
similar results in lncaP and Pc‑3 cells (data not shown). to 
further confirm the intracellular distribution of the FOXO1 
protein, we compared foXo1 expression in isolated nuclear 
fractions of leptin‑treated and non‑treated cells by western 
blotting. fig. 4B shows that foXo1 expression in the nuclei of 
leptin‑treated cells was significantly decreased to ~50% of that 
in non‑treated cells.
Long‑term exposure to leptin regulates the expression of cell 
cycle‑related proteins. as described above, long‑term expo‑
sure of leptin‑induced Pca cell proliferation resulted from 
foXo1 exclusion out of a nuclear region. We therefore next 
determined if the nuclear exclusion of foXo1 that resulted 
from long‑term exposure to leptin might affect the expression 
of cell cycle‑related proteins. increased cyclin D1 expression 
and decreased p21 expression was shown by western blotting 
of cells following long‑term leptin treatment compared to 
non‑treated cells (fig. 5), suggesting that genes that regulate 
the g1/S transition were modulated towards cell cycle progres‑
sion by leptin treatment.
Discussion
To our knowledge, this is the first report that long‑term expo‑
sure of leptin increases proliferation, migration and invasion 
of Pca cells through inactivation of foXo1.
figure 4. effects of long‑term exposure to leptin on intracellular localization of forkhead box o1 (foXo1). (a) immunocytochemical analysis of foXo1. the 
PI3K inhibitor, LY294002 (25 µM) was added into the medium containing leptin for the last 2 h of culture. FOXO1 is colored red. Cell nuclei are stained with 
the nucleic acid stain Hoechst (blue). Photographs of representative images were taken at x200 magnification. Scale bar, 50 µm. (B) FOXO1 in nuclear extracts 
of leptin‑treated and ‑untreated cells. Lamin A/C was used as a loading control of the nuclear fraction. Representative immunoblots and the quantification by 
scanning densitometry of three independent experiments are shown. Values are expressed as the means ± standard deviation (SD). *P<0.05.
figure 5. effects of long‑term leptin exposure on the expression of genes 
regulating the g1/S transition in human prostate cancer (Pca) cells. lysates 
of human Pca cells treated with or without 100 ng/ml leptin for 1 month were 
immunoblotted using anti‑cyclin D1 and p21cip (p21) antibodies. 
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Most in vitro studies of leptin have only focused on analysis 
of the short‑term effects of leptin exposure over 24‑72 h. in 
preliminary studies we analyzed the effect of short‑term leptin 
exposure on Pca cell proliferation and found that treatment 
with leptin concentrations of 0‑1,000 ng/ml for 48 h did not 
modulate Pca cell proliferation (fig. 1a). However, short‑term 
leptin exposure may not reflect the in vivo situation. thus, 
obese people are exposed to high levels of leptin over a long 
period. in addition, in humans, higher Pca risk or higher tumor 
aggression correlates with elevated leptin levels. for example, 
the study by Wang et al showed that a low‑fat diet decreased 
the tumor growth of xenografted lncaP cells (23). another 
study demonstrated that a high‑fat diet induced a high level of 
serum leptin and high argyrophilic nucleolar organizer region 
(agnor) counts in a transgenic adenocarcinoma of mouse 
prostate (traMP) model (24). these studies suggested that 
chronic hyperleptinemia might be related to Pca progression. 
the present study was therefore performed to clarify whether 
long‑time exposure (28 days) to leptin affected the aggres‑
siveness of three human Pca cell lines; lncaP, Du145 and 
Pc‑3, in vitro.
first of all, long‑term exposure to leptin significantly 
enhanced the aggressiveness of all Pca cells. leptin had 
a similar influence on both AS and AI PCa cells, although 
previous studies have not shown common effects of leptin on 
aS and ai Pca cells (20‑22). in addition, we demonstrated that 
long‑term exposure to leptin enhanced expression of the obr 
and akt phosphorylation. overexpression of leptin and the 
expression of obr have been reported to be associated with 
tumor progression in several types of cancers (25‑28). obr 
gene silencing resulted in a significant decrease in long‑term 
leptin‑induced cell proliferation. Moreover, the Pi3K inhibitor 
also suppressed cell proliferation. these results suggested that 
the Pi3K/akt signaling pathway, via obr, has an important 
role in leptin‑induced proliferation.
furthermore, we showed that the akt phosphorylation 
induced foXo1 phosphorylation. the Pi3K/akt signaling 
pathway is known to be important for foXo1 phosphoryla‑
tion (29). the foXo family is composed of four members 
(foXo1, 3a, 4, and 6) that are known to be important 
factors in many cellular processes including apoptosis, 
repair of damaged Dna, glucose metabolism and cell cycle 
arrest (29,30). foXo1 is known to function in the tumor 
suppression of several malignant tumors (31‑35). also in the 
present study, foXo1 silencing promoted the proliferation of 
all Pca cell lines examined. furthermore, foXo1 has a role as 
a transcription factor in the nucleus that regulates a large spec‑
trum of tumor suppression genes. the activities of foXos are 
controlled by post‑translational modifications such as phos‑
phorylation and acetylation (29,30,36,37). unphosphorylated 
foXo proteins usually reside only in the nucleus. once they 
are phosphorylated by intracellular environmental changes, 
they are exported to the cytoplasm and inactivated (37,38). 
foXo1 promotes cell cycle arrest in the nucleus via upregu‑
lation of cell cycle inhibitors or downregulation of cell cycle 
regulators (29,30,39). We demonstrated that Pca cell prolif‑
eration induced by long‑term exposure to leptin was a result 
of foXo1 exclusion from the nucleus. in addition, increased 
cyclin D1 expression and decreased p21 expression was shown 
following long‑term leptin treatment. these data suggest 
that leptin treatment may release these cells from cell cycle 
arrest, which foXo1 regulates in the nucleus, by exclusion of 
FOXO1 from the nucleus. These findings closely match those 
of previous studies (40,41), which indicate the induction of 
apoptosis through Pi3K/foXo1 signaling pathways. lee et al 
have shown that MHy‑449, a novel dihydrobenzofuro[4,5‑b] 
naphthyridin‑6‑one derivative, induced apoptotic cell death in 
Pc‑3 cells through a reduction in the phosphorylation of akt 
and foXo1 and induced subcellular translocation of foXo1 
from the cytoplasm to the nucleus in these cells (41).
Pca growth depends mainly on androgen signaling via the 
androgen receptor (ar). liu et al demonstrated that foXo1 
represses ar signaling, and that the nuclear localization of 
foXo1 is necessary for its inhibition (42). zhang et al also 
demonstrated that foXo1 silencing attenuates methylselenic 
acid suppression of ar activity (33). thus, in the case of aS 
Pca cells, leptin may increase ar activity by exclusion of 
foXo1 from the nucleus.
In conclusion, our findings provide supporting evidence for 
a signaling pathway between long‑term leptin treatment and 
foXo1 function and contribute to an understanding of the 
association between obesity and Pca progression.
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